Nature Communications · 2022 · 21 citations · 19 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryMolecular Cell BiologyMolecular PharmacologyCell Membrane FunctionChannel StructureCystic FibrosisCystic Fibrosis PharmacotherapyFibrosisMolecular Chaperones14-3-3 Protein Binding RegulationCftr Gene MutationsCftr Protein FunctionChloride Channel DisordersChloride Channel DysfunctionChloride TransportChloride Transport DefectsLumacaftor Therapy
Impaired activity of the chloride channel CFTR is the cause of cystic fibrosis. 14-3-3 proteins have been shown to stabilize CFTR and increase its biogenesis and activity. Here, we report the identification and mechanism of action of a macrocycle stabilizing the 14-3-3/CFTR complex. This molecule rescues plasma membrane localization and chloride transport of F508del-CFTR and works additively with the CFTR pharmacological chaperone corrector lumacaftor (VX-809) and the triple combination Trikafta®. This macrocycle is a useful tool to study the CFTR/14-3-3 interaction and the potential of molecular glues in cystic fibrosis therapeutics.
19
<i>Phaser</i>crystallographic software
Airlie J. McCoy, Ralf W. Grosse‐Kunstleve, Paul D. Adams et al. · Journal of Applied Crystallography · 2007 · 20.9K citations · Full text
Wolfgang Kabsch · Acta Crystallographica Section D Biological Crystallography · 2010 · 16.9K citations · Full text